MEDICAL TECHNOLOGY M&A MARKET DYNAMICS
- M&A activity in the Medical Technology sector remained subdued in Q2 2025, with 104 announced transactions, a decline from the 128 deals recorded in Q2 2024. To keep pace with historical annual averages, deal volume will need to accelerate in the second half of the year.
- Strategic buyers remained the primary drivers of M&A activity this quarter, accounting for nearly 60% of total deal volume, or 63 transactions.
- Activity was well-distributed across subsectors, with the Therapeutic Device segment leading at 18% of total deals. The Services and Equipment segments followed closely, accounting for 17% and 16%, respectively, reflecting a balanced and diversified M&A landscape.
